Sepsis deaths are still high, with 50% mortality within two years
Sepsis is a life-threatening complication arising from an infection, which occurs when the body’s response to the infection damages its…
Sepsis is a life-threatening complication arising from an infection, which occurs when the body’s response to the infection damages its…
Priovant Therapeutics has high expectations for its lead candidate brepocitinib and plans to evaluate the therapy in multiple autoimmune indications.…
Gilead has presented updated data for its twice-yearly pre-exposure prophylaxis (PrEP) lenacapavir, which has shown nearly perfect efficacy in two…
US-based biopharmaceutical company Adicet Bio has begun enrolling patients in a Phase I clinical trial of ADI-001 to treat autoimmune…
Union Therapeutics is looking to advance its PDE4 inhibitor, orismilast, into a Phase III clinical trial for atopic dermatitis (AD)…
UCB and Biogen’s lupus drug has met its primary endpoint in a Phase III trial, but the companies are yet…
Immunovant has reported positive results from a trial investigating its monoclonal antibody drug batoclimab in Graves’ disease patients, as its…
Aurinia Pharmaceuticals has dosed the first subject in a Phase Ia single ascending dose (SAD) clinical trial of AUR200, as…
This week on Pipeline Moves, we kick off by looking at a Phase II termination of an investigator-led trial of…
Australian biotech company Noxopharm has announced the initiation of the first-in-human clinical trial of its drug candidate, SOF-SKN, targeting the…